Rize Oncology, Inc. is a genetic medicines company, which engages in the creation of gene editing therapies based on the GeneTether platform. The company was founded by Daren Graham, William J. Garner, and R. Geoffrey Sargent on February 12, 2018 and is headquartered in Kelowna, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rize Oncology Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rize Oncology Inc. market cap is $12.12M.
What is the 52-week high for Rize Oncology Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rize Oncology Inc. 52 week high is $0.16 as of September 06, 2025.
What is the 52-week low for Rize Oncology Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rize Oncology Inc. 52 week low is $0.0004 as of September 06, 2025.
What is Rize Oncology Inc. stock price today?
Rize Oncology Inc. stock price today is $0.16.
What was Rize Oncology Inc. stock price yesterday?
Rize Oncology Inc. stock price yesterday was $0.0004.
What is the PE ratio of Rize Oncology Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rize Oncology Inc.’s P/E ratio is -9.04.
What is the Price-to-Book ratio of Rize Oncology Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rize Oncology Inc. P/B ratio is 18.6698.
What is the 50-day moving average of Rize Oncology Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rize Oncology Inc. 50-day moving average is $0.16.
